Mayne Pharma Group (ASX:MYX) said its DistributeRx unit has entered into its first third-party partnership with Resilia Pharmaceuticals to exclusively distribute Recedo topical gel through DistributeRx's prescription distribution platform, according to a Monday Australian bourse filing.
The company said DistributeRx will receive a fixed fee for each Recedo prescription filled using the platform.
The topical gel is intended for the management of old and new hypertrophic or keloid scarring resulting from burns, surgical procedures or trauma wounds, the filing added.